Hologic (NSDQ:HOLX) — a major company in the Pap and human papillomavirus (HPV) testing space — is criticizing the American Cancer Society over new cervical cancer screening recommendations that prefer simply doing HPV tests every five years. “Although all the screening tests are good at finding cancer and pre-cancer, primary HPV testing is better at finding […]
Routine screening has been touted as the most effective way to stem cancer deaths, but it may instead put patients in harm’s way, according to American Cancer Society chief medical officer Dr. Otis Brawley. Speaking at a seminar last week, Brawley warned that hospitals recommending regular screening may be looking out for their profits rather than their patients.
Nothing beats early detection in preventing deaths related to breast cancer, a coalition of patient advocacy groups said, calling for routine mammography in all women aged 40 and older.
The latest published research on mammogram use and breast cancer trends in the U.S. offered mixed messages for women who must navigate betwen the dangers of missing mammograms as well as for getting over-treated as a result of them.
A new study released by the Radiological Society of North America warned that new federal recommendations regarding breast cancer screening could result in skipped mammograms and missed cancers.
MASSDEVICE ON CALL — A nationwide urologists lobbying group largely discredited guidance from a U.S. Preventative Services Task Force recommending that physicians set aside a commonly used prostate cancer screening tool.
Known as the prostate-specific antigen test, or PSA, the tool may pose more risks than benefits, according to the panel.
A new study from the American Cancer Society shows that people with only a high school education are nearly three times more likely to die from cancer than people with college and advanced degrees. From the Associated Press story: